MHRA updated GLP-1 product information over pancreatitis risk
The MHRA issued a drug safety alert and updated product information for GLP-1 medicines to highlight acute pancreatitis as a known but infrequent side effect that can be fatal. Patients were advised to be alert to severe, persistent stomach pain that may spread to the back, with nausea or vomiting. Anyone experiencing that should seek medical attention rather than wait.
What this is. A dated, sourced note on something that changed. Peptide Register is an independent reference: it sells nothing, carries no advertising, and takes no money from any company selling any compound it covers. This is not medical advice. If a change affects a medicine you are prescribed, speak to your doctor or pharmacist rather than acting on something you read here.